Why Royal Dutch Shell Plc, AstraZeneca plc and Antofagasta plc Should Lag The FTSE 100 Today

Royal Dutch Shell Plc (LON: RDSB), AstraZeneca plc (LON: AZN) and Antofagasta plc (LON: ANTO) are having a down day.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) is retreating a little after five sessions of rises in a row, losing 32 points to 6,746 by noon. Although London’s top index has been buoyed in recent days by positive earnings, disappointing results from some of its star members lie behind today’s reversal.

We take a look at three companies holding the FTSE 100 back today:

Royal Dutch Shell

A disappointing performance miss from Royal Dutch Shell sent its shares down 109p (4.8%) to 2,168p this morning. Third-quarter earnings on a current-cost-of-supplies (CCS) basis crashed 32%, to $4.2bn from $6.2bn a year previously — a fall had been expected, but not one that big.

Also on a CCS basis, earnings per share excluding exceptional items fell 32% from a year ago, to 71 cents per share — but Shell’s quarterly dividend has been raised 5% to 45 cents per share.

Chief executive Peter Voser said “We are facing headwinds from weak industry refining margins, and the security situation in Nigeria, which continue to erode the near term outlook“, but reiterated that Shell is committed to rewarding its shareholders through dividends.

AstraZeneca

A third-quarter update from AstraZeneca also caused disappointment, with loss of exclusivity on several drug brands leading to an expected 4% fall in revenue to $6,250m. But that fall, compounded with increased research investment, led to a 20% fall in pre-tax profit to $1,592m and a 16% drop in earnings per share to 99 cents.

But on the upside, the company told us its late-stage pipeline is continuing to grow, with candidates olaparib, selumetinib and benralizumab all progressing to the Phase III clinical programme stage.

Today’s drop takes AstraZeneca shares to a P/E of 10.6 based on full-year forecasts — with a 5.5% dividend yield predicted, could they be a bargain now?

Antofagasta

Our third FTSE 100 faller today is Antofagasta (LSE: AZN), after investors reacted negatively to the copper miner’s Q3 production report.

Volumes of the brown metal were in line with expectations, with 174,200 tonnes of the stuff produced in the quarter — 3.4% down on the previous quarter, but 4.4% up year-to-date. And though output fell 11.7% on the quarter to 67,700 ounces, year-to-date production rose 8% to 230,600 ounces.

Forecasts for the full year are unchanged, but fears of a surplus of copper over the next few years pushing prices down further is what hit the share price today.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Stack of one pound coins falling over
Investing Articles

Want to turn your ISA into a passive income machine? These 3 steps help

Christopher Ruane looks at a trio of factors he reckons could help an investor as they aim to earn passive…

Read more »

Investing For Beginners

2 FTSE shares that have been oversold in this stock market correction

Jon Smith reviews the recent market slump and points out a couple of FTSE shares he believes have been oversold…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the stock market moves down, I’m taking the Warren Buffett approach!

Rather than getting nervous as markets move around, our writer is looking to the career of Warren Buffett to see…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s how a stock market crash could be brilliant news for your retirement!

This writer isn't peering into a crystal ball trying to time the next stock market crash. Instead, he's making an…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Down 93%, should I load up on this penny stock while it’s under 1p?

The small-cap company behind this penny stock is eyeing up a substantial global market opportunity. So why did it crash…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is Fundsmith Equity still worth holding in a Stocks and Shares ISA or SIPP in 2026?

The performance of the Fundsmith Equity fund has been shocking over the last two years. Is it still smart to…

Read more »

Young female hand showing five fingers.
Investing Articles

5 smart moves to make before the 2025/2026 ISA deadline

Taking advantage of the annual allowance isn’t the only smart move to make before the upcoming ISA deadline, says Edward…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Here’s the dividend forecast for Lloyds shares through to 2028

Can dividend forecasts tell investors much about the outlook for banking shares? Stephen Wright sets out what investors really need…

Read more »